Effect of α-Linolenic acid on Streptozotocin-induced diabetic retinopathy indices in vivo

Archives of Medical Research

Volumn 44, Issue 7, 2013, Pages 514-520

  Shen, Jun hui ^a,b   Ma, Qi ^b   Shen, Shen grong ^b   Xu, Guo Tong ^a   Das, Undurti N ^c,d,e  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UND Life Sciences   (United States)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^e GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

Author keywords

Linolenic acid; BDNF; Diabetic retinopathy; Interleukin 6; Polyunsaturated fatty acids; VEGF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; LINOLEIC ACID; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; INFLAMMATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES;

EID: 84887194365     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.09.010     Document Type: Article

References (44)

1. Stone J.R., Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 2002, 9:231-238.
2. 1, and PKC-ζ mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells. Am J Physiol Endocrinol Metab 2007, 293:E1280-E1288.
3. Ushio-Fukai M., Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004, 264:85-97.
4. Sapieha P., Chen J., Stahl A., et al. Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabet 2012, 2:e36.
5. Das U.N. Metabolic syndrome pathophysiology. The Role of Essential Fatty Acids 2010, Wiley-Blackwell, Ames, IA.
6. Das U.N. Molecular Basis of Health and Disease 2011, Springer, New York.
7. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000, 192:1197-1204.
8. Mukherjee P.K., Marcheselli V.L., Serhan C.N., Bazan N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004, 101:8491-8496.
9. Ren J., Han E.J., Chung S.H. Invivo and invitro anti-inflammatory activities of alpha-linolenic acid isolated from Actinidia polygama fruits. Arch Pharm Res 2007, 30:708-714.
10. Ren J., Chung S.H. Anti-inflammatory effect of alpha-linolenic acid and its mode of action through the inhibition of nitric oxide production andinducible nitric oxide synthase gene expression via NF-kappaB and mitogen-activated protein kinase pathways. J Agric Food Chem 2007, 55:5073-5080.
11. Ma Q., Shen J., Shen S., et al. Bioactive lipids in pathological retinopathy. Crit Rev Food Sci Nutr 2013, 53:1-16.
12. Das U.N. Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy. Nutrition 2013, 29:1-7.
13. Bazan N.G. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989, 312:95-112.
14. Son S.M. Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes. Diabet Metab J 2012, 36:190-198.
15. Amrite A.C., Ayalasomayajula S.P., Cheruvu N.P., Kompella U.B. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci 2006, 47:1149-1160.
16. Du Y., Sarthy V.P., Kern T.S. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol 2004, 287:R735-R741.
17. Koto T., Nagai N., Mochimaru H., et al. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 2007, 48:4328-4334.
18. Chen Y., Hao H., He S., et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol Cancer Ther 2010, 9:2164-2174.
19. Suresh Y., Das U.N. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukotrienes Essential Fatty Acids 2001, 64:37-52.
20. Suresh Y., Das U.N. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition 2003, 19:93-114.
21. Suresh Y., Das U.N. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-3 fatty acids. Nutrition 2003, 19:213-228.
22. Krishna Mohan I., Das U.N. Prevention of chemically-induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition 2001, 17:126-151.
23. Sailaja Devi M.M., Das U.N. Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells invitro. Prostaglandins Leukot Essen Fatty Acids 2004, 71:309-318.
24. Sailaja M.M.S., Das U.N. Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot Essen Fatty Acids 2006, 74:39-60.
25. Das U.N. Obesity: genes, brain, gut and environment. Nutrition 2010, 26:459-473.
26. Cao L., Lin E.J., Cahill M.C., et al. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat Med 2009, 15:447-454.
27. Bousquet M., Gibrat C., Saint-Pierre M., et al. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1401-1408.
28. Toyomoto M., Ohta M., Okumura K., et al. Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett 2004, 562:211-215.
29. Boccellino M., Giovane A., Servillo L., et al. Fatty acid mobilized by the vascular endothelial growth factor in human endothelial cells. Lipids 2002, 37:1047-1052.
30. Matesanz N., Park G., McAllister H., et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci 2010, 51:6815-6825.
31. Miyake J.A., Benadiba M., Colquhoun A. Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression. Lipids Health Dis 2009, 8:8.
32. Calviello G., Di Nicuolo F., Gragnoli S., et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 2004, 25:2303-2310.
33. Tevar R., Jho D.H., Babcock T., et al. Omega-3 fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr 2002, 26:285-289.
34. Kim Y.S., Hong S.W., Choi J.P., et al. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol 2009, 183:5113-5120.
35. Chu S.C., Tsai C.H., Yang S.F., et al. Induction of vascular endothelial growth factor gene expression by proinflammatory cytokines in human pulp and gingival fibroblasts. J Endod 2004, 30:704-707.
36. Sun D., Matsune S., Ohori J., et al. TNF-alpha and endotoxin increasehypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 2005, 32:243-249.
37. Honorati M.C., Cattini L., Facchini A. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 2004, 12:683-691.
38. Das U.N. Metabolic syndrome X: an inflammatory condition?. Curr Hypertens Rep 2004, 6:66-73.
39. Das U.N. Is metabolic syndrome X an inflammatory condition?. Exp Biol Med (Maywood) 2002, 227:989-997.
40. Huang T., Asimi S., Lou D., et al. Plasma phospholipid polyunsaturated fatty acids and homocysteine in Chinese type 2 diabetes patients. Asia Pac J Clin Nutr 2012, 21:394-399.
41. Das U.N. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essen Fatty Acids 1995, 52:387-391.
42. Krabbe K.S., Nielsen A.R., Krogh-Madsen R., et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007, 50:431-438.
43. Umashankar V., Sathya Baarathi R., Kaviarasan K., et al. Agonistic effect of polyunsaturated fatty acids (PUFAs) and its metabolites on brain-derived neurotrophic factor (BDNF) through molecular docking simulation. Lipids Health Dis 2012, 11:109.
44. Mayer K., Schmidt R., Muhly-Reinholz M., et al. Invitro mimicry of essential fatty acid deficiency in human endothelial cells by TNF-α impact of ω-3 vs. ω-6 fatty acids. J Lipid Res 2002, 43:944-951.